Eye Diseases

Common eye disease are cataracts, glaucoma, retinal disorders, and conjunctivitis.

Programs + Services


Ophthalmology (New England Eye Center)

Ophthalmology (New England Eye Center) at Tufts Medical Center in Boston specializes in the testing and treatment of all types of eye diseases and visual problems.
More information about programs and services

Doctors + Care Team

Jay S. Duker, MD

Jay S. Duker, MD

Loading ...

Accepting New Patients

Virtual Appointments Available

Title(s): New England Eye Center; Professor, Tufts University School of Medicine
Department(s): Ophthalmology
Appt. Phone: 617-636-4604
Fax #: 617-636-4866

Dr. Duker’s part-time clinical practice is limited to medical diseases of the posterior segment of the eye including age-related macular degeneration (AMD), diabetic retinopathy, retinal vascular diseases, posterior segment uveitis and intraocular tumors. He has a particular interest in rare and unusual retinal disorders, especially those connected to systemic disease.

View Full Profile for Jay S. Duker, MD

Michael H. Goldstein, MD, MM

Michael H. Goldstein, MD, MM

Loading ...

Accepting New Patients

Title(s): Co-Director, Cornea, External Disease and Cataract Service; Refractive Surgery Service; Uveitis & Immunology Service; Assistant Professor, Tufts University School of Medicine
Department(s): Ophthalmology
Appt. Phone: 617-636-0626
Fax #: 617-636-4866

Cornea and external diseases, cataract surgery, refractive surgery, uveitis and immunology

View Full Profile for Michael H. Goldstein, MD, MM

Michael B. Raizman, MD

Michael B. Raizman, MD

Loading ...

Accepting New Patients

Title(s): Co-Director, Cornea and Cataract Service; Director, Corneal Fellowship; Associate Professor, Tufts University School of Medicine
Department(s): Ophthalmology
Appt. Phone: 617-636-4600
Fax #: 617-636-4866

Cornea diseases, external diseases, anterior segment diseases, cataract surgery

View Full Profile for Michael B. Raizman, MD

Elias Reichel, MD

Elias Reichel, MD

Loading ...

Accepting New Patients

Title(s): Vice Chair for Research and Education, Department of Ophthalmology; Director, Vitreoretinal Diseases and Surgery Service; Co-Director, Electrophysiology Service; Director, Medical Retina Fellowship; Professor and Vice Chair, Department of Ophthalmology, Tufts University School of Medicine
Department(s): Ophthalmology
Appt. Phone: 617-636-4600
Fax #: 617-636-4866

Vitreoretinal diseases and surgery, diabetic eye disease, macular degeneration, hereditary retinal degenerations, retinal venous occlusive disease

View Full Profile for Elias Reichel, MD

Nadia K. Waheed, MD, MPH

Nadia K. Waheed, MD, MPH

Loading ...

Accepting New Patients

Virtual Appointments Available

Title(s): Ophthalmologist; Retina Specialist; Associate Professor, Tufts University School of Medicine
Department(s): Ophthalmology
Appt. Phone: 617-636-4600
Fax #: 617-636-4866

Vitreoretinal disease and surgery, diabetic eye disease

View Full Profile for Nadia K. Waheed, MD, MPH

Andre J. Witkin, MD

Andre J. Witkin, MD

Loading ...

Accepting New Patients

Virtual Appointments Available

Title(s): Ophthalmologist; Retina Specialist; Assistant Professor, Tufts University School of Medicine
Department(s): Ophthalmology
Appt. Phone: 617-636-4600
Fax #: 617-636-4866

Vitreoretinal surgery, retinal and macular disorders

View Full Profile for Andre J. Witkin, MD

Helen K. Wu, MD

Helen K. Wu, MD

Loading ...

Accepting New Patients

Virtual Appointments Available

Title(s): Director, Refractive Surgery Service; Cornea Specialist; Cornea, External Disease and Cataract Service; Uveitis & Immunology Service; Assistant Professor, Tufts University School of Medicine
Department(s): Ophthalmology
Appt. Phone: 617-636-4600
Fax #: 617-636-4866

Cornea and anterior segment diseases and cataract surgery, refractive surgery

View Full Profile for Helen K. Wu, MD

Research + Clinical Trials


Pistachios and Neural Macular Pigment; a Randomized Controlled Trial  

Age-related macular degeneration (AMD) is a disease that affects the retina, an integral part of the eye responsible for sensing light and relaying images to the brain. In the United States, AMD is the leading cause of irreversible vision loss as people age. Previous studies have shown that the nutrients lutein and zeaxanthin can help protect against AMD in middle aged and older adults. These nutrients form a pigment in the retina (macular pigment) that helps protect the retina from light damage. The more macular pigment in the retina, the better protection it offers.

Lutein and zeaxanthin are found in foods such as leafy green vegetables, broccoli, peas and avocados. They are also found in pistachio nuts, a bioavailable source of these nutrients. Since most people do not eat pistachio nuts daily, we are trying to see whether eating 2-ounces of pistachio nuts a day can help increase the density or amount of macular pigment in the eye.


More information about research and clinical trials


OTT166-201 A Phase 2 Randomized, Double-Masked, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of OTT166 Ophthalmic Solution in the Treatment of Diabetic Retinopathy (DR)

1. Men or women ≥18+ years of age with type 1 or 2 diabetes mellitus who have moderately severe to severe Non-proliferative Diabetic Retinopathy 2. Treatment-naïve (ie, no previous anti-VEGF or steroid treatment or PRP or laser within 1,000 μm of the foveal center/treatment for macular edema or DR in the study eye) 3. Willing and able to return for all study visits and comply with study-related procedures
More information about research and clinical trials


Randomized Trial of Bifocal Spectacles vs. Single Vision Spectacles for Esotropia Greater at Near

The study is being conducted to compare whether an optical correction of bifocal spectacle lenses (BFL) or single-vision spectacle lenses (SVL) is more effective for the treatment of children with esotropia greater at near. Children will be randomized to be treated with BFLs or SVLs for 3 years and be evaluated at regular intervals throughout the study to determine whether their condition has worsened. Children whose condition worsens during the study will either start BFL treatment (if randomized to SVL group) or continue BFL treatment (if randomized to BFL group) for 2 months to allow assessment of outcome in BFLs, and then be released to treatment at investigator discretion while continuing in study follow-up. Children whose condition has not worsened during the study will start or continue BFL (depending on treatment group) for 2 months at 3 years. All children return at 38 months to assess binocular function. The effectiveness and safety of both treatments will be compared.
More information about research and clinical trials